Pharmaceutical Technology3h
EMA CHMP recommends MSD’s KEYTRUDA for gynaecological cancers
The EMA CHMP has recommended approval of MSD’s KEYTRUDA for two gynaecological cancers: endometrial and cervical.
Pharmaceutical Technology3h
MHRA approves Takeda’s fruquintinib for metastatic colorectal cancer
Takeda UK has announced the UK's MHRA approval of fruquintinib for adults with metastatic colorectal cancer (CRC).
Pharmaceutical Technology5h
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
Pharmaceutical Technology5h
FDA approves Zevra Therapeutics’ Miplyffa for Niemann-Pick disease
Zevra Therapeutics has gained FDA approval for Miplyffa (arimoclomol) to treat Niemann-Pick disease type C (NPC).
Pharmaceutical Technology5h
C-realize IT Services
C-realize provides software solutions to help pharmaceutical clients improve product development and meet regulatory standards. C-realize works as an IT partner for the pharmaceutical, biotechnology, ...